KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Gross Margin (2016 - 2025)

Historic Gross Margin for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to 79.8%.

  • Gilead Sciences' Gross Margin rose 6700.0% to 79.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 78.72%, marking a year-over-year increase of 26000.0%. This contributed to the annual value of 78.26% for FY2024, which is 22200.0% up from last year.
  • As of Q3 2025, Gilead Sciences' Gross Margin stood at 79.8%, which was up 6700.0% from 78.81% recorded in Q2 2025.
  • Over the past 5 years, Gilead Sciences' Gross Margin peaked at 83.52% during Q3 2021, and registered a low of 63.74% during Q4 2021.
  • Its 5-year average for Gross Margin is 77.54%, with a median of 78.15% in 2023.
  • Its Gross Margin has fluctuated over the past 5 years, first crashed by -174300bps in 2021, then soared by 173700bps in 2022.
  • Over the past 5 years, Gilead Sciences' Gross Margin (Quarter) stood at 63.74% in 2021, then grew by 27bps to 81.11% in 2022, then decreased by -13bps to 70.62% in 2023, then grew by 12bps to 79.11% in 2024, then increased by 1bps to 79.8% in 2025.
  • Its Gross Margin was 79.8% in Q3 2025, compared to 78.81% in Q2 2025 and 76.9% in Q1 2025.